• Citer

Flufenamic acid and its 5-hydroxy-metabolite inhibit the specific oxidation of LDL by the myeloperoxidase/H2O2/CL-system

par Van Antwerpen, Pierre ;Zouaoui Boudjeltia, Karim ;Legssyer, Ilham ;Babar, Sajida ;Moreau, Patrick ;Moguilevsky, Nicole ;Vanhaeverbeek, Michel ;Ducobu, Jean ;Neve, Jean
Référence 14th International Society of Atherosclerosis congress(18-22 juin 2006: Rome, Italy), Atherosclerosis Supplements, Elsevier, Vol. 7, page (524)
Publication Publié, 2006

Abstract de conférence

• Détails

Titre:	Flufenamic acid and its 5-hydroxy-metabolite inhibit the specific oxidation of LDL by the myeloperoxidase/H2O2/CL-system
Auteur:	Van Antwerpen, Pierre; Zouaoui Boudjeltia, Karim; Legssyer, Ilham; Babar, Sajida; Moreau, Patrick; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Ducobu, Jean; Neve, Jean
Informations sur la publication:	14th International Society of Atherosclerosis congress(18-22 juin 2006: Rome, Italy), Atherosclerosis Supplements, Elsevier, Vol. 7, page (524)
Statut de publication:	Publié, 2006
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	MPO; LDL; inhibition; flufenamic acid
Langue:	Anglais